2K8P

Characterisation of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	250 uM [U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
2	2D 1H-13C HSQC	200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
3	2D 1H-1H TOCSY	310 uM entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
4	2D 1H-1H NOESY	310 uM entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
5	3D CBCA(CO)NH	200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
6	3D HNCACB	200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
7	3D HCCH-TOCSY	200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
8	3D 1H-13C NOESY	250 uM [U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308
9	3D 1H-13C NOESY	200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride	95% H2O/5% D2O	100	5.5	ambient atm	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
torsion angle dynamics		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	36
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
4	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.